Cyclophosphamide/epirubicin/fluorouracil/paclitaxelHart failure: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2016年 / 1585卷 / 1期

关键词：

D O I：

10.1007/s40278-016-13854-8

中图分类号：

学科分类号：

摘要：

引用

页码：87 / 87

共 50 条

[21] Cyclophosphamide/epirubicin/fluorouracilUlcer secondary to phlebitis: case report
Reactions Weekly, 2018, 1731 (1) : 87 - 87
[22] Cyclophosphamide/epirubicin/fluorouracilMelanonychia in an elderly patient: case report
Reactions Weekly, 2009, 1240 (1) : 16 - 16
[23] Epirubicin/trastuzumabHeart failure: case report
Reactions Weekly, 2017, 1649 (1) : 110 - 110
[24] Cyclophosphamide/epirubicin/fluorouracilCongenital malformations (first report with epirubicin) following in utero exposure: case report
Reactions Weekly, 2011, 1346 (1) : 17 - 17
[25] Cyclophosphamide/epirubicin/fluorouracilAcute cutaneous lupus erythematosus: case report
Reactions Weekly, 2021, 1849 (1) : 148 - 148
[26] Cyclophosphamide/epirubicin/fluorouracilLeucocytopenia and stomatitis in an elderly patient: case report
Reactions Weekly, 2013, 1444 (1) : 15 - 15
[27] Cyclophosphamide/fluorouracil/methotrexateRaynaud's disease (first report with cyclophosphamide and methotrexate): case report
Reactions Weekly, 2004, 983 (1) : 9 - 9
[28] Epirubicin/trastuzumabAcute heart failure: case report
Reactions Weekly, 2011, 1377 (1) : 17 - 17
[29] Comparison of epirubicin and vinorelbine with cyclophosphamide, epirubicin, and fluorouracil as neoadjuvant chemotherapy for operable breast cancer
Han, S.
Kwak, K.
Kim, J.
Kim, J.
Park, K.
EJC SUPPLEMENTS, 2005, 3 (02): : 122 - 122
[30] Clinical Comparison of Safety and Efficacy of Vinorelbine/Epirubicin (NE) with Fluorouracil/Epirubicin/Cyclophosphamide (FEC)
Yan, Peng-Wei
Huang, Xin-En
Jiang, Yong
Tang, Jin-Hai
Xu, Hong-xia
Xu, Xia
Jin, Xiang
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2010, 11 (04) : 1115 - 1118

← 1 2 3 4 5 →